This application is for a 5-year renewal (Years 34-38) of T32 CA09314 - Training Program in Cancer Epidemiology, Prevention, and Control at Johns Hopkins Bloomberg School of Public Health. Our mission is to train pre-doctoral students and post-doctoral fellows to be leaders at the forefront of advancing knowledge of a) causes of cancer, including inherent and modifiable factors in human populations locally, nationally, and globally; b) how to prevent and reduce burden of cancer locally, nationally, and globally by i) providing and communicating a better understanding of behaviors that influence cancer development and promote healthy survivorship, ii) identifying new markers for early detection of cancer, and iii) identifying and addressing cancer disparities including in vulnerable populations and barriers to care; and c) how to translate, implement, and evaluate cancer epidemiology, prevention, and control discoveries into populations. Our goal is to create a rich and interactive environment for trainees augmented by highly innovative, productive, and collaborative cancer research conducted by observational, basic, and clinical scientists at the Schools of Public Health and Medicine and Cancer Center. The Program has 3 tracks: 1) Cancer Etiology and Prevention, including translational research; 2) Genetic Epidemiology of Cancer, including genomics and epigenetics; and 3) Cancer Control, including disparities, communication, and tobacco. 6 pre- and 3 post-doctoral trainees pursue focused programs of shared elements across tracks: didactic courses on substantive and methodologic topics and research ethics; interactive information exchange; teaching, communication, grant writing; pre- or post-doctoral research; and program-specific education, research, and career mentoring. We stress the importance of developing and testing novel hypotheses and collaborating across disciplines. Via shared elements, trainees are exposed to current topics such as translational research, molecular epidemiology, emerging risk factors, methodologic issues in research and screening, disparities, communication, and use of epidemiology in risk assessment and public policy. 16 Preceptors, selected in part for records of advising and research, are primary mentors. 28 Affiliates provide cutting-edge expertise in specific cancers, biostatistics, and laboratory exposure assessment. With the Director, the Steering Committee is responsible for trainee selection/monitoring, and program refinement as cancer research evolves. Training duration is 4-5 yrs for pre- and 2 yrs for post-doctoral trainees. We have a strong record: the 33 pre- and 15 post-doctoral trainees in the past 10 years had cancer research training and career success. From a large pool of applicants, best candidates are recruited. Trainees represent diverse backgrounds; we received 4 CURE supplements. In summary, the Program is designed to a) provide trainees with a multidisciplinary background essential to conduct highest caliber, state-of-the-art, collaborative, translational cancer research, b) nurture them to be innovative thinkers, c) develop teaching and communication skills, d) prepare them to lead the nation's cancer research agenda in academia or elsewhere.
The Training Program is directly relevant to the burden of cancer in the US and throughout the world. The mission of this Program is to train pre-doctoral students and post-doctoral fellows to become leaders at the forefront of advancing the knowledge of a) the causes of cancer, including inherent and modifiable factors in human populations locally, nationally, and globally; b) how to prevent and reduce the burden of cancer locally, nationally, and globally by i) providing and communicating a better understanding of behaviors that influence the development of cancer and promote healthy survivorship, ii) identifying new markers for the early detection of cancer, and iii) identifying and addressing cancer disparities including in vulnerable populations and barriers to care; and c) how to translate, implement, and evaluate cancer epidemiology, prevention, and control discoveries into populations. The Program prepares trainees to be the next generation of population-based researchers who will set and address the nation's cancer research agenda with the goal of reducing cancer incidence, morbidity, recurrence, and mortality, and the disparities in cancer.
|Marrone, Michael T; Selvin, Elizabeth; Barber, John R et al. (2018) Hyperglycemia, classified with multiple biomarkers simultaneously in men without diabetes, and risk of fatal prostate cancer. Cancer Prev Res (Phila) :|
|Karia, Pritesh S; Morgan, Frederick C; Califano, Joseph A et al. (2018) Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual. JAMA Dermatol 154:175-181|
|Jones, Miranda R; Tellez-Plaza, Maria; Vaidya, Dhananjay et al. (2018) Ethnic, geographic and dietary differences in arsenic exposure in the multi-ethnic study of atherosclerosis (MESA). J Expo Sci Environ Epidemiol :|
|Marrone, Michael T; Tsilidis, Konstantinos K; Ehrhardt, Stephan et al. (2018) When is enough, enough? When are more observational epidemiologic studies needed to resolve a research question: illustrations using biomarker-cancer associations. Cancer Epidemiol Biomarkers Prev :|
|Klassen, Ann Carroll; Smith, Katherine Clegg; Shuster, Michelle et al. (2018) ""We're Just Not Prepared for Eating Over Our Whole Life"": A Mixed Methods Approach to Understanding Dietary Behaviors Among Longer Term Cancer Survivors. Integr Cancer Ther 17:350-362|
|Weber, Kari A; Heaphy, Christopher M; Joshu, Corinne E et al. (2018) Racial differences in maternal and umbilical cord blood leukocyte telomere length and their correlations. Cancer Causes Control 29:759-767|
|Hurwitz, Lauren M; Joshu, Corinne E; Barber, John R et al. (2018) Aspirin and Non-Aspirin NSAID Use and Prostate Cancer Incidence, Mortality, and Case-Fatality in the Atherosclerosis Risk in Communities Study. Cancer Epidemiol Biomarkers Prev :|
|Latkin, Carl A; Kennedy, Ryan D; Davey-Rothwell, Melissa A et al. (2018) The Relationship Between Neighborhood Disorder and Barriers to Cessation in a Sample of Impoverished Inner-City Smokers in Baltimore, Maryland, United States. Nicotine Tob Res 20:1451-1456|
|Czaplicki, Lauren; Cohen, Joanna E; Jones, Miranda R et al. (2018) Compliance with the City of Chicago's partial ban on menthol cigarette sales. Tob Control :|
|Robbins, Hilary A; Strickler, Howard D; Massad, L Stewart et al. (2017) Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach. AIDS 31:1035-1044|
Showing the most recent 10 out of 152 publications